In oncology, staging forms the basis for prognostic consideration and directly influences
patient care by determining the therapeutic approach. Cross-sectional imaging techniques …

The present, updated document describes the fourth iteration of recommendations for the
hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European …

Contrast-enhanced ultrasound (CEUS) has become an established modality in various
clinical indications for liver diseases. SonoVue®, a pure blood pure agent, and Sonazoid® …

Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004
dealing only with liver applications. A second edition of the guidelines in 2008 reflected …

The development of ultrasound contrast agents (UCAs), which perform as blood pool
tracers, have overcome the limitations of conventional B-Mode and colour or power Doppler …

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"] [German S3-guideline
"Diagnosis and treatment of esophagogastric cancer"] Z Gastroenterol. 2011 Apr;49(4):461-531 …

In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

The development of ultrasound contrast agents with excellent tolerance and safety profiles
has notably improved liver evaluation with ultrasound (US) for several applications …

Background: Shear-wave elastography (SWE) is a novel noninvasive method that involves
application of local mechanical compression on soft tissue using focused ultrasonography …

The development of microbubbles as ultrasound contrast agents (USCA) has opened the
way for new and extended applications of ultrasound in clinical practise as well as offering …